Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Oncolys BioPharma

2004 FOUNDED
PUBLIC STATUS
31-40 EMPLOYEES
4588 STOCK SYMBOL
2 INVESTMENTS
$8.09 SHARE PRICE (As of Wednesday Closing)
Description

Provider and manufacturer of drugs and pharmaceuticals. The company is engaged in manufacturing and selling drugs and other diagnostic products to its clients in Japan.

Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • Toranomon Towers Office
  • 4-1-28 Toranomon
  • Tokyo, Minato-ku 105-0001
  • Japan

+81 00-0000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Oncolys BioPharma’s full profile, request a free trial.

Oncolys BioPharma Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$4.44 - $10.62 $88.9M $6.90 -$0.98 682K 12.9M

Oncolys BioPharma Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 59,995 51,909 61,795 19,299
Revenue 2,883 2,043 1,639 1,004
EBITDA (11,069) (9,687) (8,406) (6,928)
Net Income (10,982) (9,724) (8,560) (7,094)
Total Assets 29,423 31,278 26,850 33,249
Total Debt 3,623 4,034 3,321 3,559
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Oncolys BioPharma Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 31-Mar-2017 000000000 00000 Medical Supplies
Liquid Biotech 02-Dec-2015 Seed Round 000 Other Healthcare Technology Systems
To view this company’s complete investment and acquisition history, request access »

Oncolys BioPharma Executive Team (1)

Name Title Board
Seat
Contact
Info
Namiko Yamashita Ph.D Senior Manager, Business Development